posted
***PKTX.. ***Quick Overview of Protokinetix..
….Results achieved over the last three years of testing the company is now preparing a submission to enter into phase one and two human clinical trials. Additional studies will be expanded to include whole organ transplantation.
.…AAGP™ is manufactured at facilities in North America, Europe, and Asia for shipment worldwide.
….ProtoKinetix anticipates that its future lies as a value-adding compound in two prime areas:
(1)..For challenges in regenerative medicine and the stresses resulting from the harvesting, purification, expansion, cryopreservation, and re-engraftment of cells.
(2)..For the treatment and cures of such inflammation-related conditions as diabetes, arthritis, neural-related diseases.
...Commercial Targets:
Cell and tissue protection
Stem cell preservation
Cell therapy and regenerative medicine
Organ Transplants
Blood and blood derivative preservation
-------------------- The check is in the mail... Posts: 196 | From: Florida | Registered: Dec 2009
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
